Elfabrio 2 mg/mL concentrate for solution for infusion
*Company:
Chiesi LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
File name
HUG7206 Elfabrio Risk Minim HCP Booklet IRE print v4.pdf
Reasons for updating
- Replace File
File name
HUG7206 Elfabrio Patient Carer Booklet IRE print v3.pdf
Reasons for updating
- Replace File
File name
HUG7206 Elfabrio Infusion Booklet IRE print v3.pdf
Reasons for updating
- Replace File
File name
HUG7206 Elfabrio Risk Minim HCP Booklet IRE print v4.pdf
Reasons for updating
- New EDM File
File name
HUG7206 Elfabrio Patient Carer Booklet IRE print v3.pdf
Reasons for updating
- New EDM File
File name
HUG7206 Elfabrio Infusion Booklet IRE print v3.pdf
Reasons for updating
- New EDM File
Updated on 07 June 2024
File name
Elfabrio PIL CP0088-2_IE-NI.pdf
Reasons for updating
- Change to section 2 - excipient warnings
- Change to section 6 - what the product contains
Updated on 07 June 2024
File name
Elfabrio SmPC IE-NI_CS0130-2.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 6.5 - Nature and contents of container
- Change to section 6.6 - Special precautions for disposal and other handling
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 17 May 2023
File name
Elfabrio SmPC EU_CS0130-1.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 17 May 2023
File name
Elfabrio PIL CP0080-1_EU+GB.pdf
Reasons for updating
- New PIL for new product
Updated on 17 May 2023
File name
Elfabrio SmPC EU_CS0130-1.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Chiesi Limited
Address:
Chiesi Limited, 333 Styal Road, Manchester, M22 5LGMedical Information E-mail:
Medinfo.uk@chiesi.comTelephone:
+44 (0) 161 488 5555 , 1800 817 459Website:
https://www.chiesi.uk.com https://www.chiesimedical.co.ukMedical Information Direct Line:
+44 (0)1748 827 271Stock Availability:
CustomerServices.UK@chiesi.com